Tumor proliferation and metastatic spread are promoted by neutrophils that are recruited by cancer-related chemokines and cytokines (e.g., IL-6 and TNF) which are highly present in advanced cancer patients and which are also associated with drug resistance (53, 54). Here, IL6 is linked to cancer.